Dimethylglycine sodium salt protects against oxidative damage and mitochondrial dysfunction in the small intestines of mice

Int J Mol Med. 2019 May;43(5):2199-2211. doi: 10.3892/ijmm.2019.4093. Epub 2019 Feb 11.

Abstract

Few studies have investigated the use of dimethylglycine sodium salt (DMG‑Na) to protect against small intestinal damage, despite its prevalence in the treatment of human diseases. The present study aimed to evaluate the protective effects of DMG‑Na against oxidative damage and mitochondrial dysfunction in the small intestines of mice. A total of 100 male Kunming mice were randomly assigned to five groups (n=20 per group): i) Mice gastric intubation with 0.3 ml sterile saline solution (once), then subcutaneously injected with sterile saline solution (0.5 ml) after 1 h (CON); ii) mice gastric intubation with 12 mg DMG‑Na/0.3 ml of sterile saline solution once, then subcutaneously injected with sterile saline solution (0.5 ml) 1 h later (D); iii) mice gastric intubation with 0.3 ml sterile saline solution once, then subcutaneously injected with indomethacin (10 mg/kg BW) 1 h later (IN); iv) mice gastric intubation with 12 mg DMG‑Na/0.3 ml sterile saline solution once, then subcutaneously injected with indomethacin (10 mg/kg BW) 1 h later (DIN); and v) mice subcutaneously injected with indomethacin (10 mg/kg BW), then gastrically intubated with 12 mg DMG‑Na/0.3 ml sterile saline solution once after 1 h (IND). The present study was evaluated the effects of DMG‑Na on mice intestinal damage induced by indomethacin injection. The histological morphology of the small intestine improved (P<0.05) in the DIN and IND groups, compared with the IN group. The antioxidant system was enhanced, oxidative damage was reduced, and the expression of antioxidant‑associated genes was increased in the small intestine and its mitochondria in the DIN and IND groups, compared with the IN group. The above results suggested that pretreatment and treatment with DMG‑Na reduced oxidative damage by enhancing antioxidant capacity, increasing the expression of antioxidant‑associated genes, ameliorating mitochondrial dysfunction and suppressing apoptosis. Further study is required to determine the specific mechanism by which pretreatment and treatment with DMG‑Na reduced small intestinal damage.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Gene Expression Regulation / drug effects
  • Indomethacin
  • Intestine, Small / drug effects
  • Intestine, Small / pathology*
  • Male
  • Mice
  • Mitochondria / metabolism
  • Mitochondria / pathology*
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects*
  • Protective Agents / pharmacology*
  • Sarcosine / analogs & derivatives*
  • Sarcosine / pharmacology

Substances

  • Antioxidants
  • Protective Agents
  • dimethylglycine
  • Indomethacin
  • Sarcosine